2-(3′,5′-Dimethoxybenzylidene) (DMBC) produces neuroprotection against pMCAO insult.
DMBC directly protects HT22 cell and astrocytes against OGD insult.
DMBC inhibits the ischemia or OGD-induced activation of cathepsin B.
DMBC treatment blocks the ischemia or OGD-induced release of cathepsin B.